Pharma funds

Drug companies and their trade groups employed 1,100 lobbyists and spent $155 million on federal lobbying efforts last year, according to the Center for Public Integrity. Topping any single company, PhRMA spent more than $18 million on lobbying last year and $104 million since 1998. Meanwhile, BIO spent $5.4 million last year and almost $35 million in the same nine-year span. Pfizer spent $12 million last year, more than any other firm. In comparison, Amgen spent over $10 million, Sanofi spent $6.7 million, and Merck spent just over $4 million...